← Clinical Evidence

SRC-55445a4e3ef4 Gallagher CL 2011

Evidence source and scope

A longitudinal study of motor performance and striatal [18F]fluorodopa uptake in Parkinson’s disease.

This note indexes a cited or audit-added source. It may be an original study, review, guideline, form or methods reference. Treat the specific design and the evidence below as authoritative; a source note is not automatically a primary study.

DOI: 10.1007/s11682-011-9124-5

Bibliographic record from the original reports

Access labels embedded in these original reference strings are historical. Current access and exact checked components are stated separately below.

Gallagher CL, Johnson SC, Bendlin BB, Chung MK, Holden JE, Oakes TR, et al. A longitudinal study of motor performance and striatal [18F]fluorodopa uptake in Parkinson’s disease. Brain Imaging Behav. 2011;5(3):203–211. DOI 10.1007/s11682-011-9124-5

Conditions: COND-PD Parkinson’s disease

Scoped audit evidence

These are source- and component-level audit summaries as of 3 October 2026. Access and comparison scope can differ by report; none certifies every result or the underlying raw data.

Parkinson’s disease — strength

STR-64-01

Limitations: Only current scoped checks; archived captures not authenticated against live originals.

Parkinson’s disease strength

Parkinson’s disease strength component — Longitudinal pinch-control design and limitations

Methods confirms 26 PD/11 controls, 19 PD with three visits and seven with two, mean 1.8-year spacing, separate maximal pinch/200-g control tasks, and baseline OFF/later usual medication. Models relate control to FDOPA; outliers were replaced at±2 SD.

Source locator: Methods Procedures, Hand Motor Tests, Data Analysis;Results;Limitations

Limitations: AI-assisted source comparison; no raw-data verification.

Reports citing this source

Update record

Updating the wiki · Evidence and status guide